Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma

Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry

Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit

Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July